Who is sponsoring NCT03433014?

NCT03433014 is sponsored by Mahidol University.

What condition does NCT03433014 study?

NCT03433014 studies Laparoscopic Colorectal Surgery, Colorectal Cancer.

What drugs are being tested in NCT03433014?

Interventions: 0.5% Levobupivacaine, Control.

What is the status of NCT03433014?

NCT03433014 is currently COMPLETED.

Last reviewed 2021-09-02 · How we verify

Local Wound Infiltration With 0.5% Levobupivacaine for Postoperative Pain After Laparoscopic Colorectal Surgery.

NCT03433014 NA COMPLETED

The study design is a prospective randomized, double-blind, controlled trial of patients who are due to have elective laparoscopic colorectal surgery in Ramathibodhi Hospital. The primary objective is to measure pain scores (Visual Analog Scale) in the postoperative period. The secondary objective is to compare the VAS scores between the two types of technique used for specimen retrieval incision.After approval by the ethics committee, patients scheduled for elective laparoscopic colorectal surgery under general anesthesia who are eligible for inclusion criteria were recruited for this study after informed consent by surgical residents or surgical staff at the Outpatient Department (OPD). Patients who meet the exclusion criteria will be excluded.

Details

Lead sponsor	Mahidol University
Phase	NA
Status	COMPLETED
Enrolment	30
Start date	Sat Mar 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Dec 30 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Laparoscopic Colorectal Surgery
Colorectal Cancer

Interventions

0.5% Levobupivacaine
Control

Countries

Thailand